2m 2m 2m 2m 2m 2m 2m
NEUROPACE (NPCE)
NASDAQ
$15.86-$0.43 (-2.64%)
Price as of Jun 03, 2026 5:01 PM EDT- $563.9MMarket Cap
- 20.31%1-Year Change
- Medical DevicesIndustry
NEUROPACE (NPCE)
$15.86-$0.43 (-2.64%)
NPCE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.29 | ||
Change | -$0.22 (-1.33%) | ||
Open | $16.31 | ||
High | $16.99 | ||
Low | $16.27 | ||
Previous Close | $16.51 | ||
Volume | 203,469 | ||
30-Day Average Volume | 215,663 | ||
1-Week Change | -2.34% | ||
1-Month Change | -4.57% | ||
1-Year Change | 20.31% | ||
3-Year Change | 296.35% | ||
5-Year Change | -27.57% | ||
Fundamentals | |||
Shares Outstanding | 34.1M | ||
Total Assets | $98.9M | ||
Market Cap | $563.9M | ||
Enterprise Value | $608.2M | ||
Period: QTR TTM FY | |||
Revenue | $22.1M | ||
Net Income | -$6.7M | ||
Free Cash Flow | -$6.0M | ||
EBIT | -$5.2M | ||
EBITDA | -$5.1M | ||
Net Working Capital | N/A | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -119 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 39 | ||
P/E | -83 | ||
PEG | 1 | ||
Price/Free Cash Flow | -94 | ||
Price/Operating Cash Flow | -96 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue